Advertisement
Screener

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Depreciation

2.8 / 5 stars · 68/120 Roast Me

NATURAL ALTERNATIVES INTERNATIONAL INC Depreciation

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Depreciation of $1.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-19.

Financial Statements › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2026-05-19

  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for the quarter ending 2026-03-31 was $1.20M, a 9.09% increase year-over-year.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for the quarter ending 2025-12-31 was $1.10M, a 8.33% decline year-over-year.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for the quarter ending 2025-09-30 was $1.20M, a 9.09% increase year-over-year.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for the quarter ending 2025-06-30 was $1.20M, a 0.00% change year-over-year.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for fiscal 2025 was $4.60M, a 0.00% change from fiscal 2024.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for fiscal 2024 was $4.60M, a 6.98% increase from fiscal 2023.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for fiscal 2023 was $4.30M, a 2.38% increase from fiscal 2022.
  • NATURAL ALTERNATIVES INTERNATIONAL INC depreciation for fiscal 2022 was $4.20M, a 2.33% decline from fiscal 2021.
Period endDepreciation 3 monthDepreciation 6 monthDepreciation 9 monthDepreciation 12 month
2026-03-31$1.20M
10-Q · filed 2026-05-19
$2.30M
derived: sum of 2 quarters · filed 2026-05-19
$3.50M
10-Q · filed 2026-05-19
$4.70M
derived: sum of 4 quarters · filed 2026-05-19
2025-12-31$1.10M
10-Q · filed 2026-02-13
$2.30M
10-Q · filed 2026-02-13
$3.50M
derived: sum of 3 quarters · filed 2026-02-13
$4.60M
derived: sum of 4 quarters · filed 2026-05-19
2025-09-30$1.20M
10-Q · filed 2025-11-12
$2.40M
derived: sum of 2 quarters · filed 2025-11-12
$3.50M
derived: sum of 3 quarters · filed 2026-05-19
$4.70M
derived: sum of 4 quarters · filed 2026-05-19
2025-06-30$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$2.30M
derived: sum of 2 quarters · filed 2026-05-19
$3.50M
derived: sum of 3 quarters · filed 2026-05-19
$4.60M
10-K · filed 2025-09-23
2025-03-31$1.10M
10-Q · filed 2026-05-19
$2.30M
derived: sum of 2 quarters · filed 2026-05-19
$3.40M
10-Q · filed 2026-05-19
$4.60M
derived: sum of 4 quarters · filed 2026-05-19
2024-12-31$1.20M
10-Q · filed 2026-02-13
$2.30M
10-Q · filed 2026-02-13
$3.50M
derived: sum of 3 quarters · filed 2026-02-13
$4.60M
derived: sum of 4 quarters · filed 2026-02-13
2024-09-30$1.10M
10-Q · filed 2025-11-12
$2.30M
derived: sum of 2 quarters · filed 2025-11-12
$3.40M
derived: sum of 3 quarters · filed 2025-11-12
$4.60M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$2.30M
derived: sum of 2 quarters · filed 2025-09-23
$3.50M
derived: sum of 3 quarters · filed 2025-09-23
$4.60M
10-K · filed 2025-09-23
2024-03-31$1.10M
10-Q · filed 2025-05-14
$2.30M
derived: sum of 2 quarters · filed 2025-05-14
$3.40M
10-Q · filed 2025-05-14
$4.60M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$1.20M
10-Q · filed 2025-02-14
$2.30M
10-Q · filed 2025-02-14
$3.50M
derived: sum of 3 quarters · filed 2025-02-14
$4.50M
derived: sum of 4 quarters · filed 2025-02-14
2023-09-30$1.10M
10-Q · filed 2023-11-09
$2.30M
derived: sum of 2 quarters · filed 2024-09-27
$3.30M
derived: sum of 3 quarters · filed 2024-09-27
$4.40M
derived: sum of 4 quarters · filed 2024-09-27
2023-06-30$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27
$2.20M
derived: sum of 2 quarters · filed 2024-09-27
$3.30M
derived: sum of 3 quarters · filed 2024-09-27
$4.30M
10-K · filed 2024-09-27
2023-03-31$1.00M
10-Q · filed 2024-05-14
$2.10M
derived: sum of 2 quarters · filed 2024-05-14
$3.10M
10-Q · filed 2024-05-14
$4.00M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$1.10M
10-Q · filed 2024-02-13
$2.00M
10-Q · filed 2024-02-13
$3.00M
derived: sum of 3 quarters · filed 2024-02-13
$4.20M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30$1.00M
10-Q · filed 2023-11-09
$1.90M
derived: sum of 2 quarters · filed 2023-11-09
$3.10M
derived: sum of 3 quarters · filed 2023-11-09
$4.20M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$900.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-21
$2.10M
derived: sum of 2 quarters · filed 2023-09-21
$3.20M
derived: sum of 3 quarters · filed 2023-09-21
$4.20M
10-K · filed 2023-09-21
2022-03-31$1.20M
10-Q · filed 2023-05-15
$2.30M
derived: sum of 2 quarters · filed 2023-05-15
$3.30M
10-Q · filed 2023-05-15
2021-12-31$1.10M
10-Q · filed 2023-02-08
$2.20M
10-Q · filed 2023-02-08
2021-09-30$1.10M
10-Q · filed 2022-11-09
2021-06-30$4.30M
10-K · filed 2022-09-21
2020-06-30$4.00M
10-K · filed 2021-09-20
2019-06-30$3.50M
10-K · filed 2020-09-21
2018-06-30$2.90M
10-K · filed 2019-09-24
2017-06-30$2.30M
10-K · filed 2018-09-19
2016-06-30$1.80M
10-K · filed 2017-09-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87